These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 23827118)
1. [Clinical characteristics of 8 patients with B-cell prolymphocytic leukemia]. Zhang YR; Li ZJ; Yu Z; Yi SH; Feng XY; Zou DH; Qi JY; Zhao YZ; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):544-5. PubMed ID: 23827118 [No Abstract] [Full Text] [Related]
2. An unusual cause of delirium and debility: refractory hypercalcemia in a man with B-cell prolymphocytic leukemia. Loh KP; Dahiya S; Brennan MJ J Am Geriatr Soc; 2014 Oct; 62(10):2021-2. PubMed ID: 25333559 [No Abstract] [Full Text] [Related]
3. [Splenic irradiation as a successful treatment for an elderly patient with B-cell prolymphocytic leukemia]. Nakashima H; Saito B; Ariizumi H; Matsuda I; Nakamaki T; Tomoyasu S Rinsho Ketsueki; 2008 Dec; 49(12):1619-22. PubMed ID: 19110524 [TBL] [Abstract][Full Text] [Related]
4. De novo B-cell prolymphocytic leukemia with central nervous system involvement. Tatarczuch M; Blombery P; Seymour JF Leuk Lymphoma; 2014 Jul; 55(7):1665-7. PubMed ID: 24047478 [No Abstract] [Full Text] [Related]
6. Relapsed B-cell prolymphocytic leukemia (B-PLL) with distinctive granular inclusion bodies. Su MY; Chen TC; Teng CJ; Wu CH Int J Lab Hematol; 2024 Aug; 46(4):585-586. PubMed ID: 38284307 [No Abstract] [Full Text] [Related]
7. Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B-cell clones. Cao F; Amato D; Wang C Am J Hematol; 2011 Sep; 86(9):782. PubMed ID: 21465516 [No Abstract] [Full Text] [Related]
8. Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. Fiegl M; Stauder R; Steurer M; Mian M; Hopfinger G; Brychtova Y; Skrabs C; Zabernigg A; Schmid F; Haslbaur F; Winder G; Walder A; Lang A; Voskova D; Greil R; Mayer J; Gastl G; Ann Hematol; 2014 Feb; 93(2):267-77. PubMed ID: 24292560 [TBL] [Abstract][Full Text] [Related]
9. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947 [TBL] [Abstract][Full Text] [Related]
10. Acute visual change as first symptom of B-cell prolymphocytic leukaemia. Hawley L; Eaton O; Han L N Z Med J; 2023 Apr; 136(1573):114-116. PubMed ID: 37054461 [TBL] [Abstract][Full Text] [Related]
11. B-cell prolymphocytic leukaemia with a t(4;14) FGFR3/IGH translocation: response to ibrutinib. George P; Brown A; Weinkove R Pathology; 2020 Jun; 52(4):491-492. PubMed ID: 32349864 [No Abstract] [Full Text] [Related]
12. A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia. Tempescul A; Feuerbach J; Ianotto JC; Dalbies F; Marion V; Le Bris MJ; De Braekeleer M; Berthou C Ann Hematol; 2009 Jan; 88(1):85-8. PubMed ID: 18654781 [No Abstract] [Full Text] [Related]